Bruker (BRKRP) Other Accumulated Expenses (2010 - 2026)

Bruker has reported Other Accumulated Expenses for 17 years, with the latest figure at $597.9 million in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses rose 1.0% year-over-year to $597.9 million; the trailing twelve-month figure through Mar 2026 stood at $597.9 million (up 1.0% YoY), and the FY2025 full-year result was $605.4 million, up 1062.0% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $597.9 million, down from $605.4 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $605.4 million in Q4 2025, with the low at $4.3 million in Q4 2023.
• Historically, Other Accumulated Expenses has averaged $424.9 million across 5 years, with a median of $493.6 million in 2022.
• Annual changes were most pronounced in 2023 — Other Accumulated Expenses plunged 89.76% — and 2024, when it soared 1111.63%.
• Bruker's Other Accumulated Expenses stood at $42.0 million in 2022, then sank by 89.76% to $4.3 million in 2023, then soared by 1111.63% to $52.1 million in 2024, then surged by 1062.0% to $605.4 million in 2025, then dropped by 1.24% to $597.9 million in 2026.
• The last three Other Accumulated Expenses figures came in at $597.9 million (Q1 2026), $605.4 million (Q4 2025), and $604.0 million (Q3 2025), per Business Quant data.